| Catalog No. |
Size |
Price |
Figures |
|---|
Z00134-1 mg
| 1 mg | $ 420.00 |
References:
- Cividini A, et al. Kinetics and significance of serum hepatitis C virus core antigen in patients with acute hepatitis C. J. Clin. Microbiol. May 2003; 41(5): 2144-2146
- Netski DM, et al. Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users. J. Clin. Microbiol. Apr 2004; 42(4): 1631-1636.
- Gaudy C, et al. Usefulness of the hepatitis C virus core antigen assay for screening of a population undergoing routine medical checkup. J. Clin. Microbiol. Apr 2005; 43(4): 1722-1726.
|
|---|
| Full Name | | Hepatitis C Virus (HCV) Nucleocapsid Genotype 5 |
|
| Abbreviated Name-1 | Hepatitis NG5 |
|---|
| Abbreviated Name-2 | rHCVNG5 |
|---|
| Description | E. coli derived recombinant. The protein Hepatitis C Virus (HCV) Nucleocapsid Genotype 5 contains the HCV core nucleocapsid immunodominant regions, amino acids 2-119. Hepatitis C Virus core proteins are purified by proprietary chromatographic techniques.
|
|---|
| Source | E. coli |
|---|
| Purity | Protein is >95% pure as determined by 10% PAGE (coomassie staining). |
|---|
| Storage | Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
|---|
| Concentration | 1 mg/ml in 25 mM Tris-HCl, 1 mM EDTA, 1.5 M urea, 50% glycerol. |
|---|
| Stability | Five years frozen. One month in solution at room temperature. |
|---|
| Specificity | Immunoreactive with sera of HCV-infected individuals, including sera with antibodies to NS3 secondary domains. |
|---|
| Applications | Antigen in ELISA and Western blots, excellent antigen for detection of HCV with minimal specificity problems. |
|---|
